Literature DB >> 2676659

Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.

M Borkman1, D J Chisholm, S M Furler, L H Storlien, E W Kraegen, L A Simons, C N Chesterman.   

Abstract

Fish oils, containing omega-3 fatty acids (omega 3FAs), favorably influence plasma lipoproteins in nondiabetic humans and prevent the development of insulin resistance induced by fat feeding in rats. We studied the effects of fish oils in 10 subjects (aged 42-65 yr) with mild non-insulin-dependent diabetes mellitus (NIDDM). Subjects were fed a standard diabetic diet plus 1) no supplementation (baseline), 2) 10 g fish oil concentrate (30% omega 3FAs) daily, and 3) 10 g safflower oil daily over separate 3-wk periods, the latter two supplements being given in radom order by use of a double-blind crossover design. At the end of each diet period, fasting blood glucose (FBG), insulin, and lipids were measured, and insulin sensitivity was assessed with a hyperinsulinemic-euglycemic clamp performed with [3-3H]glucose. FBG increased 14% during fish oil and 11% during safflower oil supplementation compared with baseline (P less than .05), whereas body weight, fasting serum insulin levels, and insulin sensitivity were unchanged. The absolute increase in FBG during each supplementation period correlated with the baseline FBG (fish oil, r = .83, P less than .005); safflower oil, r = .75, P = .012). Fasting plasma triglyceride levels decreased during fish oil supplementation in the 4 subjects with baseline hypertriglyceridemia (greater than 2 mM) but were not significantly reduced overall. There was no significant change in fasting plasma total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. In summary, dietary fish oil supplementation adversely affected glycemic control in NIDDM subjects without producing significant beneficial effects on plasma lipids. The effect of safflower oil supplementation was not significantly different from fish oil, suggesting that the negative effects on glucose metabolism may be related to the extra energy or fat intake.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676659     DOI: 10.2337/diab.38.10.1314

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

1.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.

Authors:  J Hartweg; A J Farmer; R R Holman; H A W Neil
Journal:  Diabetologia       Date:  2006-11-21       Impact factor: 10.122

Review 2.  Specific lipid lowering therapy in the management of diabetes.

Authors:  P N Durrington
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 3.  Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions.

Authors:  Nicholas P Hays; Pietro R Galassetti; Robert H Coker
Journal:  Pharmacol Ther       Date:  2008-03-02       Impact factor: 12.310

Review 4.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 5.  Dietary fats and insulin action.

Authors:  L H Storlien; L A Baur; A D Kriketos; D A Pan; G J Cooney; A B Jenkins; G D Calvert; L V Campbell
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

6.  Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.

Authors:  E Corpeleijn; E J M Feskens; E H J M Jansen; M Mensink; W H M Saris; T W A de Bruin; E E Blaak
Journal:  Diabetologia       Date:  2006-08-03       Impact factor: 10.122

Review 7.  Metabolic and therapeutic lessons from genetic manipulation of GLUT4.

Authors:  M J Charron; E B Katz
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 8.  Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases.

Authors:  Francisco J Schopfer; Dario A Vitturi; Diane K Jorkasky; Bruce A Freeman
Journal:  Nitric Oxide       Date:  2018-06-23       Impact factor: 4.427

9.  Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial.

Authors:  Shaylika Chauhan; Hanish Kodali; Jawad Noor; Karuna Ramteke; Vidisha Gawai
Journal:  J Clin Diagn Res       Date:  2017-03-01

10.  Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus.

Authors:  Manas Kaushik; Dariush Mozaffarian; Donna Spiegelman; JoAnn E Manson; Walter C Willett; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2009-07-22       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.